SS

Sunita Singh

Active Director Director DIN 05359184
DIN 05359184 First appointment Jun 2014 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2014
Shareholding value •••• Premium profile

About Sunita Singh

Data last updated:

Sunita Singh is a Director at Jetlife Pharma Private Limited (since 2014). The company operates in Chemicals. Jetlife Pharma Private Limited reported revenue of ₹2.4 Lakh (FY 2019).

DIN 05359184
Primary Designation Director
Industry Chemicals
First Appointment 25 Jun 2014
Oldest Company Age 12 yrs
Largest company Jetlife Pharma Private Limited · ₹2.4 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jetlife Pharma Private Limited U24100UP2014PTC064473
Director25 Jun 20142014₹2.4 Lakh (FY 2019)Active

Board colleagues of Sunita Singh

NameDINCompanyDesignation
Naresh Singh05359181Jetlife Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Jetlife Pharma Private Limited
Premium access

Shareholding and investment profile for Sunita Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunita Singh

Sunita Singh currently holds 1 directorship: Jetlife Pharma Private Limited (Director, since 25 Jun 2014, revenue ₹2.4 Lakh (FY 2019)).

Sunita Singh was first appointed on 25 Jun 2014 as Director at Jetlife Pharma Private Limited.

The current boards of Sunita Singh's companies include Naresh Singh (Jetlife Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available